$prog no shares left, ssr, on reg sho, insane cost to borrow. Utilization almost 100% almost 70% of ff in shorts. Now forming inverse head and shoulders.....could get spicy
Biotech company Progenity’s stock has been falling apart since last year’s IPO.
But following a share price bump of around 140% since late September, experts see $PROG rising another 45%.
https://t.co/OhGwiajxBV